Bambusa Therapeutics, Inc.
Filing history at a glance
The reported offering amount was $8,999,974 in the Jan 8, 2025 filing and $88,879,860 in the Feb 26, 2025 filing. The two records may concern different offerings. All 3 stored filings from Jan 8, 2025 to Feb 26, 2025 are original notices.
through Feb 26, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 8, 2025 · D | Feb 26, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $8,999,974 | $88,879,860 | $79,879,886 |
| Reported amount sold | $8,999,974 | $53,267,941 | $44,267,967 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002044950-25-000002 · Later SEC source: 0002044950-25-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $88,879,860
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $53,267,941
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Stipple Bio, Inc. · CIK 1932776
Form D filings (3)
-
0002044950-25-000003D · Feb 26, 2025 · BiotechnologyOffering: $88,879,860Sold: $53,267,941
Compared with 0002044950-25-000002:
- Reported offering amount: $8,999,974 → $88,879,860
- Reported amount sold: $8,999,974 → $53,267,941
-
0002044950-25-000002D · Jan 8, 2025 · BiotechnologyOffering: $8,999,974Sold: $8,999,974
Same filing date; order cannot be established.
-
0002044950-25-000001D · Jan 8, 2025 · BiotechnologyOffering: $5,099,997Sold: $5,099,997